Key result
Radiotherapy-sparing strategy in pediatric synovial sarcoma yields ~85% five-year overall survival.
Why the study?
It was unclear if modified indications of radiotherapy or radical surgery compromised survival in pediatric localized synovial sarcoma.
Does a sparing strategy omitting radiotherapy compromise survival in children with non-metastatic synovial sarcoma?
Comparison
Modified radiotherapy and surgery indications sparing strategy vs standard treatment approach
Design
Prospective cohort analysis from three trials
Follow-up
5 years
Authors
Loading...
Supports selective radiotherapy sparing in pediatric synovial sarcoma; hypothesis-generating and requires prospective validation before practice change.
Cohort (n=88)
Yes
Does a sparing strategy omitting radiotherapy compromise survival in children with non-metastatic synovial sarcoma?
A sparing strategy omitting radiotherapy in selected pediatric patients with localized synovial sarcoma achieves 5-year overall survival of 85%, comparable to published data.
Orbach et al. (2011) conducted a cohort in Pediatric localized synovial sarcoma (n=88). Radiotherapy-sparing strategy was evaluated on 5-year overall survival (OS) and event-free survival (EFS). A radiotherapy-sparing strategy in pediatric localized synovial sarcoma resulted in 5-year event-free and overall survival rates of 68% and 85%, respectively, with only 32% receiving radiotherapy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: